# ğŸ“ MedFocus PhD - EspecificaÃ§Ã£o TÃ©cnica Completa
## Terminal de InteligÃªncia ClÃ­nica de PrÃ³xima GeraÃ§Ã£o

> **VersÃ£o:** 1.0  
> **Data:** Fevereiro 2026  
> **Status:** EspecificaÃ§Ã£o TÃ©cnica - Ready for Implementation  
> **Objetivo:** Superar Whitebook, UpToDate e AMBOSS com inteligÃªncia clÃ­nica em tempo real

---

## ğŸ“‹ Ãndice

1. [VisÃ£o e Posicionamento](#visÃ£o-e-posicionamento)
2. [Arquitetura TÃ©cnica GCP](#arquitetura-tÃ©cnica-gcp)
3. [Data Lakehouse MÃ©dico](#data-lakehouse-mÃ©dico)
4. [Modelo de Dados Firestore](#modelo-de-dados-firestore)
5. [As 4 Telas Principais](#as-4-telas-principais)
6. [Sistema de Busca SemÃ¢ntica](#sistema-de-busca-semÃ¢ntica)
7. [IntegraÃ§Ã£o de APIs Externas](#integraÃ§Ã£o-de-apis-externas)
8. [Sistema de Curadoria e Trust Layer](#sistema-de-curadoria-e-trust-layer)
9. [Stack TecnolÃ³gica Completa](#stack-tecnolÃ³gica-completa)
10. [Roadmap de ImplementaÃ§Ã£o](#roadmap-de-implementaÃ§Ã£o)
11. [Estimativas e Recursos](#estimativas-e-recursos)

---

## ğŸ¯ VisÃ£o e Posicionamento

### O Problema

**Whitebook, UpToDate e AMBOSS** sÃ£o ferramentas passivas de consulta:
- âŒ Dados estÃ¡ticos (atualizaÃ§Ãµes lentas)
- âŒ Busca por palavra-chave (nÃ£o entende contexto)
- âŒ Sem integraÃ§Ã£o com fontes regulatÃ³rias em tempo real
- âŒ NÃ£o diferencia urgÃªncia vs profundidade acadÃªmica
- âŒ Zero colaboraÃ§Ã£o da comunidade mÃ©dica

### A SoluÃ§Ã£o: MedFocus PhD

**Terminal de InteligÃªncia ClÃ­nica** que opera em 3 camadas:

#### Camada 1: PlantÃ£o (Always Available)
- âš¡ **SLA: 99.99% uptime**
- ğŸ“± Offline-first (cache local de condutas essenciais)
- ğŸš€ Resposta < 200ms
- ğŸ’Š Doses, calculadoras, fluxogramas de emergÃªncia

#### Camada 2: Especialista (Clinical Decision Support)
- ğŸ§  Busca semÃ¢ntica com contexto clÃ­nico
- ğŸ“Š CritÃ©rios diagnÃ³sticos detalhados
- ğŸ’‰ Drug interactions em tempo real
- ğŸ”¬ Guidelines das sociedades mÃ©dicas

#### Camada 3: PhD/Frontier (Research Intelligence)
- ğŸ“š Ãšltimos 5 RCTs de cada patologia
- ğŸ§¬ Mecanismos moleculares interativos
- ğŸ“ˆ GrÃ¡ficos de trials com endpoints
- ğŸ“– ExportaÃ§Ã£o de citaÃ§Ãµes (BibTeX, RIS, ABNT)
- ğŸŒ Alertas de novos estudos (PubMed)

### Diferencial Competitivo

| Recurso | Whitebook | UpToDate | AMBOSS | **MedFocus PhD** |
|---------|-----------|----------|--------|------------------|
| **Condutas BÃ¡sicas** | âœ… | âœ… | âœ… | âœ…âœ… (offline) |
| **Busca SemÃ¢ntica** | âŒ | âš ï¸ | âš ï¸ | âœ…âœ… (NLP) |
| **IntegraÃ§Ã£o ANVISA** | âŒ | âŒ | âŒ | âœ…âœ… (real-time) |
| **Alertas FDA** | âŒ | âš ï¸ | âŒ | âœ…âœ… |
| **PubMed Live** | âŒ | âš ï¸ | âš ï¸ | âœ…âœ… (Ãºltimos 5 RCTs) |
| **Modo PhD** | âŒ | âŒ | âŒ | âœ…âœ… (Ãºnico) |
| **ColaboraÃ§Ã£o MÃ©dica** | âŒ | âŒ | âŒ | âœ…âœ… (verificada) |
| **ExportaÃ§Ã£o CitaÃ§Ãµes** | âŒ | âŒ | âŒ | âœ…âœ… (BibTeX/RIS) |
| **TransparÃªncia (Audit Trail)** | âŒ | âŒ | âŒ | âœ…âœ… |
| **PreÃ§o (estudante)** | ğŸ’°ğŸ’° | ğŸ’°ğŸ’°ğŸ’° | ğŸ’°ğŸ’° | ğŸ’° (freemium) |

---

## ğŸ—ï¸ Arquitetura TÃ©cnica GCP

### VisÃ£o Geral da Arquitetura

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                     CLIENT LAYER                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Flutter App (iOS/Android)    â”‚    React Web (PWA)          â”‚
â”‚  - Offline-first (Hive)       â”‚    - Service Worker         â”‚
â”‚  - Local cache (50MB)         â”‚    - IndexedDB cache        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚                            â”‚
                   â–¼                            â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                  GOOGLE CLOUD PLATFORM                       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚         CLOUD LOAD BALANCER (Global)               â”‚    â”‚
â”‚  â”‚         - SSL Termination                          â”‚    â”‚
â”‚  â”‚         - DDoS Protection                          â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                     â”‚                                       â”‚
â”‚     â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                  â”‚
â”‚     â–¼               â–¼                   â–¼                   â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”      â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”           â”‚
â”‚  â”‚   API   â”‚  â”‚  Search  â”‚      â”‚   Static    â”‚           â”‚
â”‚  â”‚ Gateway â”‚  â”‚  Engine  â”‚      â”‚   Assets    â”‚           â”‚
â”‚  â”‚  (Kong) â”‚  â”‚  (Algoliaâ”‚      â”‚  (CDN/GCS)  â”‚           â”‚
â”‚  â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”˜  â”‚   or     â”‚      â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜           â”‚
â”‚       â”‚       â”‚ Elastic) â”‚                                 â”‚
â”‚       â”‚       â””â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”˜                                 â”‚
â”‚       â”‚             â”‚                                       â”‚
â”‚  â”Œâ”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚          MICROSERVICES (Cloud Run)                â”‚    â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”‚
â”‚  â”‚                                                    â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚    â”‚
â”‚  â”‚  â”‚   Auth       â”‚  â”‚   Content    â”‚             â”‚    â”‚
â”‚  â”‚  â”‚   Service    â”‚  â”‚   Service    â”‚             â”‚    â”‚
â”‚  â”‚  â”‚ (Always On)  â”‚  â”‚ (Auto-scale) â”‚             â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚    â”‚
â”‚  â”‚                                                    â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚    â”‚
â”‚  â”‚  â”‚   Clinical   â”‚  â”‚   Drug       â”‚             â”‚    â”‚
â”‚  â”‚  â”‚   Decision   â”‚  â”‚   Database   â”‚             â”‚    â”‚
â”‚  â”‚  â”‚   Service    â”‚  â”‚   Service    â”‚             â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚    â”‚
â”‚  â”‚                                                    â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚    â”‚
â”‚  â”‚  â”‚   Research   â”‚  â”‚   Integrationâ”‚             â”‚    â”‚
â”‚  â”‚  â”‚   Service    â”‚  â”‚   Service    â”‚             â”‚    â”‚
â”‚  â”‚  â”‚   (PhD Mode) â”‚  â”‚ (APIs ext.)  â”‚             â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚    â”‚
â”‚  â”‚                                                    â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚    â”‚
â”‚  â”‚  â”‚ Collaborationâ”‚  â”‚  Analytics   â”‚             â”‚    â”‚
â”‚  â”‚  â”‚   Service    â”‚  â”‚   Service    â”‚             â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚              DATA LAYER                            â”‚    â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”‚
â”‚  â”‚                                                     â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚    â”‚
â”‚  â”‚  â”‚   Firestore  â”‚  â”‚   BigQuery   â”‚              â”‚    â”‚
â”‚  â”‚  â”‚ (Operational)â”‚  â”‚ (Data Lake)  â”‚              â”‚    â”‚
â”‚  â”‚  â”‚  - Real-time â”‚  â”‚  - Analytics â”‚              â”‚    â”‚
â”‚  â”‚  â”‚  - User data â”‚  â”‚  - ML models â”‚              â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚    â”‚
â”‚  â”‚                                                     â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚    â”‚
â”‚  â”‚  â”‚  Cloud SQL   â”‚  â”‚   Memorystoreâ”‚              â”‚    â”‚
â”‚  â”‚  â”‚ (PostgreSQL) â”‚  â”‚    (Redis)   â”‚              â”‚    â”‚
â”‚  â”‚  â”‚  - Relations â”‚  â”‚  - Caching   â”‚              â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚    â”‚
â”‚  â”‚                                                     â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”              â”‚    â”‚
â”‚  â”‚  â”‚ Cloud Storageâ”‚  â”‚  Vertex AI   â”‚              â”‚    â”‚
â”‚  â”‚  â”‚ (GCS Bucket) â”‚  â”‚  - NLP/LLM   â”‚              â”‚    â”‚
â”‚  â”‚  â”‚  - PDFs/Imgs â”‚  â”‚  - Embeddingsâ”‚              â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜              â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚         INTEGRATION LAYER (Cloud Tasks)            â”‚    â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”‚
â”‚  â”‚                                                     â”‚    â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚    â”‚
â”‚  â”‚  â”‚  ANVISA  â”‚  â”‚ OpenFDA  â”‚  â”‚  PubMed  â”‚        â”‚    â”‚
â”‚  â”‚  â”‚  Crawler â”‚  â”‚   API    â”‚  â”‚   API    â”‚        â”‚    â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”˜        â”‚    â”‚
â”‚  â”‚       â”‚             â”‚             â”‚               â”‚    â”‚
â”‚  â”‚       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜               â”‚    â”‚
â”‚  â”‚                     â”‚                              â”‚    â”‚
â”‚  â”‚              â”Œâ”€â”€â”€â”€â”€â”€â–¼â”€â”€â”€â”€â”€â”€â”                      â”‚    â”‚
â”‚  â”‚              â”‚  BigQuery   â”‚                      â”‚    â”‚
â”‚  â”‚              â”‚  Ingestion  â”‚                      â”‚    â”‚
â”‚  â”‚              â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                      â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”    â”‚
â”‚  â”‚         OBSERVABILITY (Cloud Monitoring)           â”‚    â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤    â”‚
â”‚  â”‚  - Cloud Logging                                   â”‚    â”‚
â”‚  â”‚  - Cloud Trace                                     â”‚    â”‚
â”‚  â”‚  - Error Reporting                                 â”‚    â”‚
â”‚  â”‚  - Uptime Checks                                   â”‚    â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### MicroserviÃ§os Detalhados

#### 1. **Auth Service** (Always-On)
**Responsabilidade:** AutenticaÃ§Ã£o e autorizaÃ§Ã£o  
**Stack:** Node.js + Express + Firebase Auth  
**SLA:** 99.99%  
**Scaling:** Sempre 3+ instÃ¢ncias (multi-region)

**Endpoints:**
```
POST   /auth/register
POST   /auth/login
POST   /auth/refresh
GET    /auth/verify-token
POST   /auth/verify-crm  (verifica CRM mÃ©dico)
```

**Features:**
- JWT com refresh tokens
- OAuth2 (Google, Facebook)
- 2FA (TOTP)
- VerificaÃ§Ã£o de CRM (integraÃ§Ã£o CFM)
- Rate limiting (100 req/min por IP)

---

#### 2. **Content Service** (Auto-scale)
**Responsabilidade:** Gerenciamento de conteÃºdo mÃ©dico (condutas, protocolos)  
**Stack:** Node.js + Express + Firestore  
**SLA:** 99.9%  
**Scaling:** Auto-scale (1-20 instÃ¢ncias)

**Endpoints:**
```
GET    /content/conduct/:id
GET    /content/search
GET    /content/pathology/:cid
POST   /content/contribute  (mÃ©dicos verificados)
GET    /content/updates     (changelog)
```

**Features:**
- Versionamento de conteÃºdo (Git-like)
- AprovaÃ§Ã£o por curadoria (3 mÃ©dicos)
- Cache agressivo (Redis, 1h TTL)
- Offline package generation

---

#### 3. **Clinical Decision Service** (Critical)
**Responsabilidade:** Calculadoras, algoritmos clÃ­nicos, scores  
**Stack:** Python + FastAPI + NumPy  
**SLA:** 99.9%  
**Scaling:** Auto-scale (2-10 instÃ¢ncias)

**Endpoints:**
```
POST   /calculate/risk-score
POST   /calculate/drug-dose
POST   /calculate/clearance
GET    /algorithms/tree/:condition
```

**Features:**
- 100+ calculadoras mÃ©dicas
- Algoritmos de decisÃ£o (Ã¡rvores)
- Ajuste de dose renal/hepÃ¡tico
- InteraÃ§Ãµes medicamentosas

---

#### 4. **Drug Database Service**
**Responsabilidade:** Banco de dados de medicamentos  
**Stack:** Node.js + PostgreSQL + Redis  
**SLA:** 99.9%  
**Scaling:** Auto-scale (2-10 instÃ¢ncias)

**Endpoints:**
```
GET    /drug/search?q=enalapril
GET    /drug/:id/interactions
GET    /drug/:id/dosage
POST   /drug/check-interactions  (mÃºltiplos medicamentos)
GET    /drug/class/:therapeutic-class
```

**Fonte de Dados:**
- ANVISA BulÃ¡rio EletrÃ´nico (scraping diÃ¡rio)
- DrugBank (open data)
- Rename (MinistÃ©rio da SaÃºde)
- OpenFDA (alertas internacionais)

---

#### 5. **Research Service (PhD Mode)**
**Responsabilidade:** IntegraÃ§Ã£o com literatura cientÃ­fica  
**Stack:** Python + FastAPI + Vertex AI  
**SLA:** 99.5%  
**Scaling:** Auto-scale (1-5 instÃ¢ncias)

**Endpoints:**
```
GET    /research/pubmed/latest/:condition
POST   /research/export-citations
GET    /research/rct/:disease  (Ãºltimos 5 RCTs)
GET    /research/guidelines/:society
POST   /research/ai-summary   (Vertex AI summarization)
```

**Features:**
- PubMed E-utilities integration
- Filtros automÃ¡ticos (RCTs, meta-anÃ¡lises)
- ExportaÃ§Ã£o BibTeX/RIS/ABNT
- Summarization com Gemini/Vertex AI
- Alert system (novos estudos)

---

#### 6. **Integration Service**
**Responsabilidade:** IntegraÃ§Ã£o com APIs externas  
**Stack:** Python + FastAPI + Cloud Tasks  
**SLA:** 95% (nÃ£o-crÃ­tico)  
**Scaling:** Auto-scale (1-5 instÃ¢ncias)

**APIs Integradas:**

**ANVISA (Brasil):**
- DOU (DiÃ¡rio Oficial da UniÃ£o) scraping
- BulÃ¡rio EletrÃ´nico
- Alertas de farmacovigilÃ¢ncia
- Registro de genÃ©ricos

**OpenFDA (EUA):**
```
https://api.fda.gov/drug/label.json
https://api.fda.gov/drug/event.json  (adverse events)
```

**NCBI PubMed:**
```
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/
```

**Sociedades MÃ©dicas:**
- SBC (Sociedade Brasileira de Cardiologia) - RSS feed
- SBPT (Pneumologia) - PDF parsing
- AHA (American Heart Association) - API
- ESC (European Society of Cardiology) - RSS

---

#### 7. **Collaboration Service**
**Responsabilidade:** DiscussÃµes, contribuiÃ§Ãµes da comunidade  
**Stack:** Node.js + Firestore + Cloud Pub/Sub  
**SLA:** 99%  
**Scaling:** Auto-scale (1-5 instÃ¢ncias)

**Endpoints:**
```
GET    /collab/threads/:conduct-id
POST   /collab/thread
POST   /collab/reply
POST   /collab/vote
POST   /collab/report  (denÃºncia)
GET    /collab/feed    (timeline)
```

**Features:**
- Threads de discussÃ£o por conduta
- Upvote/Downvote (Reddit-like)
- ModeraÃ§Ã£o por badges (mÃ©dicos verificados)
- Feed de atividades
- NotificaÃ§Ãµes real-time (Firestore listeners)

---

#### 8. **Analytics Service**
**Responsabilidade:** Tracking, mÃ©tricas, ML  
**Stack:** Python + BigQuery + Vertex AI  
**SLA:** 95%  
**Scaling:** Auto-scale (1-3 instÃ¢ncias)

**Endpoints:**
```
POST   /analytics/track-event
GET    /analytics/user-stats/:user-id
GET    /analytics/content-popularity
POST   /analytics/predict-needs  (ML recommendation)
```

**Features:**
- Event tracking (busca, leitura, calculadoras)
- User behavior analysis
- Content recommendation (Vertex AI)
- A/B testing framework

---

## ğŸ—„ï¸ Data Lakehouse MÃ©dico

### Arquitetura do Data Lake (BigQuery)

```
BigQuery Dataset: medfocus_lakehouse
â”œâ”€â”€ raw_data/
â”‚   â”œâ”€â”€ anvisa_raw           (dados brutos ANVISA)
â”‚   â”œâ”€â”€ fda_raw              (dados brutos FDA)
â”‚   â”œâ”€â”€ pubmed_raw           (artigos PubMed)
â”‚   â””â”€â”€ guidelines_raw       (PDFs de sociedades)
â”‚
â”œâ”€â”€ processed/
â”‚   â”œâ”€â”€ drugs_processed      (medicamentos normalizados)
â”‚   â”œâ”€â”€ studies_processed    (RCTs processados)
â”‚   â”œâ”€â”€ guidelines_processed (diretrizes estruturadas)
â”‚   â””â”€â”€ alerts_processed     (alertas consolidados)
â”‚
â”œâ”€â”€ enriched/
â”‚   â”œâ”€â”€ drug_interactions    (matriz de interaÃ§Ãµes)
â”‚   â”œâ”€â”€ evidence_scores      (scores de evidÃªncia)
â”‚   â”œâ”€â”€ clinical_pathways    (fluxogramas decisÃ£o)
â”‚   â””â”€â”€ embeddings           (vetores semÃ¢nticos - Vertex AI)
â”‚
â””â”€â”€ analytics/
    â”œâ”€â”€ user_behavior        (eventos de uso)
    â”œâ”€â”€ content_performance  (popularidade de conteÃºdo)
    â”œâ”€â”€ search_queries       (queries e resultados)
    â””â”€â”€ ml_features          (features para modelos)
```

### Pipeline de IngestÃ£o

**DiÃ¡rio (Cloud Scheduler + Cloud Functions):**
```python
# Cloud Function: anvisa_daily_scraper
def scrape_anvisa(event, context):
    """
    Scrape ANVISA DOU para novos registros de medicamentos
    """
    dou_url = "https://www.in.gov.br/consulta"
    # Scraping logic
    # Parse HTML
    # Insert into BigQuery raw_data/anvisa_raw
    # Trigger Cloud Task para processamento
```

**HorÃ¡rio (a cada 6h):**
```python
# Cloud Function: fda_alerts_fetcher
def fetch_fda_alerts(event, context):
    """
    Busca novos alertas no OpenFDA
    """
    url = "https://api.fda.gov/drug/event.json?limit=100"
    # Fetch API
    # Insert into BigQuery raw_data/fda_raw
```

**Semanal:**
```python
# Cloud Function: guidelines_updater
def update_guidelines(event, context):
    """
    Checa RSS feeds de sociedades mÃ©dicas
    """
    societies = ['SBC', 'SBPT', 'AHA', 'ESC']
    for society in societies:
        # Fetch RSS
        # Download PDF se novo
        # Upload to GCS
        # Trigger Vertex AI Document AI para parsing
```

### Processamento (Cloud Dataflow)

**Pipeline: Drug Enrichment**
```python
import apache_beam as beam

def enrich_drug_data(element):
    """
    Enriquecer dados de medicamento com mÃºltiplas fontes
    """
    drug = element
    
    # Buscar ANVISA
    anvisa_data = fetch_anvisa(drug['name'])
    
    # Buscar FDA
    fda_data = fetch_fda(drug['name'])
    
    # Buscar DrugBank
    drugbank_data = fetch_drugbank(drug['id'])
    
    # Merge
    enriched = {
        **drug,
        'anvisa': anvisa_data,
        'fda': fda_data,
        'drugbank': drugbank_data,
        'last_updated': datetime.now()
    }
    
    return enriched

# Pipeline
(p
 | 'Read from BigQuery' >> beam.io.ReadFromBigQuery(table='raw_data.drugs')
 | 'Enrich' >> beam.Map(enrich_drug_data)
 | 'Write to BigQuery' >> beam.io.WriteToBigQuery(table='enriched.drugs')
)
```

---

## ğŸ“Š Modelo de Dados Firestore

### Estrutura de Documentos

#### Collection: `conducts` (Condutas MÃ©dicas)

```json
{
  "id": "conduct_icc_2026",
  "version": "3.2",
  "last_updated": "2026-02-15T10:30:00Z",
  "audit_trail": [
    {
      "editor": "user_dr_joao_123",
      "timestamp": "2026-02-15T10:30:00Z",
      "changes": "AtualizaÃ§Ã£o de dose de Sacubitril/Valsartan conforme ESC 2025",
      "approved_by": ["user_dr_maria_456", "user_dr_carlos_789"]
    }
  ],
  
  "pathology": {
    "name": "InsuficiÃªncia CardÃ­aca Congestiva",
    "cid10": "I50.0",
    "cid11": "BA00",
    "synonyms": ["ICC", "IC", "Heart Failure"],
    "category": "Cardiologia"
  },
  
  "layers": {
    "layer_1_plantao": {
      "summary": "IC descompensada: Furosemida 40mg IV, RestriÃ§Ã£o hÃ­drica, O2 se SpO2 <90%",
      "emergency_flowchart_url": "gs://medfocus/flowcharts/ic_emergency.svg",
      "key_drugs": [
        {
          "drug_id": "drug_furosemida",
          "dose": "40-80mg IV",
          "frequency": "12/12h",
          "route": "Intravenosa",
          "monitoring": "Diurese, eletrÃ³litos, creatinina"
        }
      ],
      "calculators": ["calc_nyha", "calc_dose_furosemida"],
      "evidence_level": "A",
      "guideline": {
        "source": "SBC 2025",
        "url": "https://..."
      }
    },
    
    "layer_2_especialista": {
      "diagnostic_criteria": {
        "framingham": {
          "major": ["Dispneia paroxÃ­stica noturna", "Edema agudo de pulmÃ£o"],
          "minor": ["Hepatomegalia", "Taquicardia >120bpm"]
        },
        "ecocardiograma": {
          "fe_reduced": "<40%",
          "fe_preserved": "â‰¥50%",
          "fe_mid_range": "40-49%"
        }
      },
      
      "treatment_algorithm": {
        "fe_reduced": {
          "step_1": "IECA ou BRA",
          "step_2": "Betabloqueador",
          "step_3": "Espironolactona",
          "step_4": "Sacubitril/Valsartan (se FE <35%)"
        }
      },
      
      "subgroups": [
        {
          "name": "IC com FE preservada",
          "treatment": "Controle de comorbidades, diurÃ©ticos se congestÃ£o"
        }
      ],
      
      "contraindications": [
        "IECA: GestaÃ§Ã£o, Angioedema prÃ©vio, Estenose bilateral de artÃ©ria renal"
      ],
      
      "monitoring": {
        "labs": ["Creatinina", "PotÃ¡ssio", "BNP/NT-proBNP"],
        "imaging": ["Ecocardiograma (6-12 meses)"]
      }
    },
    
    "layer_3_phd": {
      "mechanism": {
        "description": "IC resulta de sobrecarga hemodinÃ¢mica crÃ´nica â†’ remodelamento ventricular â†’ ativaÃ§Ã£o neuro-hormonal (SNS, SRAA) â†’ retenÃ§Ã£o de Na/H2O",
        "interactive_diagram_url": "gs://medfocus/diagrams/ic_mechanism_interactive.html"
      },
      
      "latest_rcts": [
        {
          "pmid": "35678901",
          "title": "EMPEROR-Preserved: Empagliflozin in Heart Failure with Preserved EF",
          "year": 2025,
          "journal": "New England Journal of Medicine",
          "n": 5988,
          "primary_endpoint": "CV death or HF hospitalization: HR 0.79 (95% CI 0.69-0.90)",
          "conclusion": "Empagliflozin reduz eventos em IC-FEp",
          "citation_bibtex": "@article{EMPEROR2025, ...}",
          "full_text_url": "https://www.nejm.org/..."
        }
      ],
      
      "molecular_targets": [
        {
          "target": "Neprilisina",
          "drug": "Sacubitril",
          "mechanism": "InibiÃ§Ã£o da degradaÃ§Ã£o de peptÃ­deos natriurÃ©ticos"
        }
      ],
      
      "controversy": [
        {
          "topic": "Timing de Sacubitril/Valsartan",
          "debate": "Iniciar precocemente vs aguardar otimizaÃ§Ã£o de IECA/BRA?",
          "references": ["PMID:35678902", "PMID:35678903"]
        }
      ],
      
      "export_citation": {
        "bibtex": "...",
        "ris": "...",
        "abnt": "..."
      }
    }
  },
  
  "trust_seal": {
    "level": "green",  // green, blue, yellow
    "description": "Baseado em Diretriz SBC 2025",
    "validators": [
      {
        "user_id": "user_dr_joao_123",
        "crm": "CRM-SP 123456",
        "specialty": "Cardiologia",
        "institution": "InCor USP",
        "timestamp": "2026-02-15T10:30:00Z"
      }
    ],
    "evidence_grade": "A",
    "last_review": "2026-02-15"
  },
  
  "collaboration": {
    "thread_id": "thread_icc_001",
    "contributions_count": 23,
    "last_contribution": "2026-02-20T14:00:00Z"
  },
  
  "analytics": {
    "views": 15234,
    "unique_users": 3456,
    "avg_time_spent": 245,  // segundos
    "layer_distribution": {
      "layer_1": 0.60,
      "layer_2": 0.30,
      "layer_3": 0.10
    }
  }
}
```

#### Collection: `drugs`

```json
{
  "id": "drug_enalapril_001",
  "generic_name": "Enalapril",
  "brand_names": ["Renitec", "Vasopril", "Eupressin"],
  "therapeutic_class": "IECA (Inibidor da ECA)",
  "atc_code": "C09AA02",
  
  "anvisa": {
    "registration_number": "1234567890",
    "status": "VÃ¡lido",
    "last_update": "2026-01-15",
    "bula_url": "https://consultas.anvisa.gov.br/..."
  },
  
  "fda": {
    "black_box_warnings": [
      "Contraindicado na gestaÃ§Ã£o - Categoria D"
    ],
    "adverse_events": {
      "total_reports": 15678,
      "serious": 2345,
      "death": 123
    }
  },
  
  "pharmacology": {
    "mechanism": "InibiÃ§Ã£o da ECA â†’ reduÃ§Ã£o de Angiotensina II â†’ vasodilataÃ§Ã£o",
    "absorption": "60% oral",
    "half_life": "11 horas (ativo: enalaprilat)",
    "metabolism": "HepÃ¡tica (prÃ³-droga)",
    "excretion": "Renal (60%)"
  },
  
  "indications": [
    "HipertensÃ£o arterial sistÃªmica",
    "InsuficiÃªncia cardÃ­aca",
    "PÃ³s-IAM com disfunÃ§Ã£o de VE"
  ],
  
  "contraindications": [
    "GestaÃ§Ã£o",
    "Angioedema prÃ©vio com IECA",
    "Estenose bilateral de artÃ©ria renal"
  ],
  
  "dosage": {
    "adult": {
      "has": {
        "initial": "5mg 1x/dia",
        "maintenance": "10-20mg 1-2x/dia",
        "max": "40mg/dia"
      },
      "ic": {
        "initial": "2.5mg 2x/dia",
        "target": "10mg 2x/dia",
        "titration": "Dobrar dose a cada 2 semanas se tolerado"
      }
    },
    "pediatric": {
      "dose": "0.1-0.5 mg/kg/dia",
      "max": "20mg/dia"
    },
    "renal_impairment": {
      "clcr_30_60": "Reduzir 50%",
      "clcr_10_30": "Reduzir 75%",
      "hemodialysis": "2.5mg pÃ³s-diÃ¡lise"
    }
  },
  
  "adverse_effects": {
    "common": ["Tosse seca (10-20%)", "Tontura", "Cefaleia"],
    "serious": ["Angioedema (0.1-0.5%)", "Hipercalemia", "InsuficiÃªncia renal aguda"]
  },
  
  "interactions": [
    {
      "drug": "Espironolactona",
      "severity": "moderate",
      "mechanism": "Risco de hipercalemia",
      "management": "Monitorar K+ semanalmente no inÃ­cio"
    },
    {
      "drug": "AINEs",
      "severity": "moderate",
      "mechanism": "ReduÃ§Ã£o do efeito anti-hipertensivo + risco renal",
      "management": "Evitar uso crÃ´nico"
    }
  ],
  
  "monitoring": {
    "baseline": ["Creatinina", "PotÃ¡ssio", "PA"],
    "follow_up": ["Creatinina e K+ em 1-2 semanas", "PA em 2-4 semanas"]
  },
  
  "pregnancy": {
    "category": "D",
    "description": "Contraindicado - risco de malformaÃ§Ãµes fetais"
  },
  
  "cost": {
    "brazil": {
      "generic": "R$ 5-15/mÃªs",
      "brand": "R$ 30-50/mÃªs"
    },
    "sus_available": true
  }
}
```

#### Collection: `calculators`

```json
{
  "id": "calc_timi_risk_score",
  "name": "TIMI Risk Score (IAM)",
  "category": "Cardiologia",
  "type": "risk_stratification",
  
  "description": "EstratificaÃ§Ã£o de risco em pacientes com IAM sem supra de ST",
  
  "variables": [
    {
      "id": "age",
      "label": "Idade â‰¥65 anos",
      "type": "boolean",
      "points": 1
    },
    {
      "id": "risk_factors",
      "label": "â‰¥3 Fatores de risco (HAS, DM, dislipidemia, tabagismo, histÃ³ria familiar)",
      "type": "boolean",
      "points": 1
    },
    {
      "id": "known_cad",
      "label": "DAC conhecida (estenose â‰¥50%)",
      "type": "boolean",
      "points": 1
    },
    {
      "id": "aspirin",
      "label": "Uso de AAS nos Ãºltimos 7 dias",
      "type": "boolean",
      "points": 1
    },
    {
      "id": "angina",
      "label": "Angina grave (â‰¥2 episÃ³dios em 24h)",
      "type": "boolean",
      "points": 1
    },
    {
      "id": "st_deviation",
      "label": "Desvio de ST â‰¥0.5mm",
      "type": "boolean",
      "points": 1
    },
    {
      "id": "troponin",
      "label": "Troponina elevada",
      "type": "boolean",
      "points": 1
    }
  ],
  
  "interpretation": {
    "0-1": {
      "risk": "Baixo",
      "mortality_14d": "4.7%",
      "recommendation": "Considerar estratÃ©gia conservadora"
    },
    "2": {
      "risk": "Baixo-IntermediÃ¡rio",
      "mortality_14d": "8.3%",
      "recommendation": "EstratificaÃ§Ã£o invasiva se troponina positiva"
    },
    "3-4": {
      "risk": "IntermediÃ¡rio-Alto",
      "mortality_14d": "13.2%",
      "recommendation": "EstratificaÃ§Ã£o invasiva precoce (<24h)"
    },
    "5-7": {
      "risk": "Alto",
      "mortality_14d": "26.2%",
      "recommendation": "EstratificaÃ§Ã£o invasiva urgente (<2h)"
    }
  },
  
  "references": [
    {
      "citation": "Antman EM, et al. JAMA. 2000;284:835-842.",
      "pmid": "10938172"
    }
  ],
  
  "formula": "sum(points)",
  "unit": "pontos",
  
  "validation": {
    "cohort": "TIMI 11B, ESSENCE",
    "n": 7081,
    "c_statistic": 0.65
  }
}
```

#### Collection: `collaboration_threads`

```json
{
  "id": "thread_icc_debate_sacubitril",
  "conduct_id": "conduct_icc_2026",
  "type": "discussion",
  
  "author": {
    "user_id": "user_dr_ana_987",
    "name": "Dra. Ana Silva",
    "crm": "CRM-RJ 987654",
    "specialty": "Cardiologia",
    "institution": "Hospital Samaritano RJ",
    "verified": true,
    "reputation": 2345
  },
  
  "title": "Timing ideal para iniciar Sacubitril/Valsartan",
  
  "content": "Caros colegas, tenho observado que muitos pacientes com IC-FEr chegam ao ambulatÃ³rio jÃ¡ em uso de IECA/BRA otimizado. VocÃªs tÃªm iniciado Sacubitril/Valsartan imediatamente ou aguardam algum perÃ­odo? O PARADIGM-HF exigia 4 semanas de IECA estÃ¡vel, mas serÃ¡ que isso se aplica Ã  prÃ¡tica?",
  
  "created_at": "2026-02-20T14:00:00Z",
  "updated_at": "2026-02-20T14:00:00Z",
  
  "votes": {
    "upvotes": 23,
    "downvotes": 2,
    "score": 21
  },
  
  "replies": [
    {
      "id": "reply_001",
      "author": {
        "user_id": "user_dr_pedro_654",
        "name": "Dr. Pedro Costa",
        "crm": "CRM-SP 654321",
        "specialty": "Cardiologia",
        "verified": true
      },
      "content": "Dra. Ana, excelente pergunta! Na minha prÃ¡tica no InCor, temos iniciado apÃ³s 4 semanas de IECA estÃ¡vel, conforme protocolo do PARADIGM-HF. Recentemente publicamos um estudo observacional...",
      "created_at": "2026-02-20T15:30:00Z",
      "votes": {
        "upvotes": 18,
        "score": 18
      },
      "references": [
        {
          "pmid": "35678904",
          "title": "Timing of Sacubitril/Valsartan initiation in clinical practice",
          "journal": "Arq Bras Cardiol"
        }
      ]
    }
  ],
  
  "tags": ["IC-FEr", "Sacubitril/Valsartan", "PARADIGM-HF"],
  
  "moderation": {
    "status": "approved",
    "flagged": false,
    "reviewed_by": "moderator_001"
  },
  
  "analytics": {
    "views": 1234,
    "unique_viewers": 567,
    "avg_time_spent": 180
  }
}
```

#### Collection: `user_phd_library` (My PhD)

```json
{
  "user_id": "user_student_maria_123",
  
  "folders": [
    {
      "id": "folder_ic",
      "name": "InsuficiÃªncia CardÃ­aca - DissertaÃ§Ã£o",
      "created_at": "2026-01-10T10:00:00Z",
      "color": "#FF6B6B"
    }
  ],
  
  "saved_articles": [
    {
      "id": "saved_001",
      "pmid": "35678901",
      "folder_id": "folder_ic",
      "title": "EMPEROR-Preserved: Empagliflozin in Heart Failure with Preserved EF",
      "authors": ["Anker SD", "Butler J"],
      "journal": "N Engl J Med",
      "year": 2025,
      "citation": {
        "bibtex": "@article{Anker2025, ...}",
        "ris": "TY  - JOUR\nAU  - Anker, SD\n...",
        "abnt": "ANKER, SD et al. EMPEROR-Preserved..."
      },
      "notes": "Importante para minha revisÃ£o - empagliflozin reduz eventos",
      "highlights": ["HR 0.79", "FEp"],
      "saved_at": "2026-02-15T16:00:00Z"
    }
  ],
  
  "export_history": [
    {
      "id": "export_001",
      "timestamp": "2026-02-20T10:00:00Z",
      "format": "bibtex",
      "articles_count": 45,
      "download_url": "gs://medfocus/exports/user_student_maria_123/export_001.bib"
    }
  ],
  
  "alerts": [
    {
      "id": "alert_001",
      "type": "new_study",
      "condition": "InsuficiÃªncia CardÃ­aca",
      "frequency": "weekly",
      "last_sent": "2026-02-17T09:00:00Z"
    }
  ]
}
```

---

## ğŸ¨ As 4 Telas Principais (UX/UI)

### Tela 1: O "Cockpit" (Home HÃ­brida)

**Componentes:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  [ğŸ” Busca Universal]  [ğŸ‘¤ Perfil]  [ğŸ“š My PhD]  [âš™ï¸]      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  ğŸ” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚     â”‚ "Paciente 70 anos, IC com FE reduzida..."       â”‚   â”‚
â”‚     â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚        ğŸ’¡ SugestÃµes: InsuficiÃªncia CardÃ­aca FEr          â”‚
â”‚                       Dose de Sacubitril/Valsartan       â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  ğŸ“° TendÃªncias em Cardiologia (sua especialidade)  â”‚   â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤   â”‚
â”‚  â”‚  ğŸ”¥ Novo RCT: Empagliflozin em IC-FEp              â”‚   â”‚
â”‚  â”‚     NEJM â€¢ HÃ¡ 2 dias â€¢ 1.2k visualizaÃ§Ãµes           â”‚   â”‚
â”‚  â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚   â”‚
â”‚  â”‚  ğŸ“Š AtualizaÃ§Ã£o SBC 2026: Diretrizes de IC         â”‚   â”‚
â”‚  â”‚     SBC â€¢ HÃ¡ 1 semana                               â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚ ğŸ§®           â”‚  â”‚ ğŸ“‹           â”‚  â”‚ ğŸ’Š           â”‚     â”‚
â”‚  â”‚ Calculadoras â”‚  â”‚ CID-11       â”‚  â”‚ BulÃ¡rio      â”‚     â”‚
â”‚  â”‚              â”‚  â”‚ Browse       â”‚  â”‚ ANVISA       â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚                                                              â”‚
â”‚  ğŸ“š Recentemente Acessado:                                  â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”‚
â”‚  â”‚ IAM STEMI  â”‚ â”‚ Sepse      â”‚ â”‚ PCR        â”‚             â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Features:**
- **Busca Universal:** NLP (Vertex AI) para entender queries clÃ­nicas
- **Cards de TendÃªncia:** Personalizados por especialidade do usuÃ¡rio
- **Acesso RÃ¡pido:** Ãcones grandes para calculadoras, CID, bulÃ¡rio
- **Recentemente Acessado:** HistÃ³rico de condutas consultadas

---

### Tela 2: VisÃ£o em Camadas (O Diferencial)

**Layout:**

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â† Voltar    InsuficiÃªncia CardÃ­aca Congestiva             â”‚
â”‚              CID-10: I50.0 | CID-11: BA00                   â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ [NÃ­vel 1: PlantÃ£o] [NÃ­vel 2: Especialista] [NÃ­vel 3: PhD] â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  ğŸš¨ EMERGÃŠNCIA - IC DESCOMPENSADA                   â”‚   â”‚
â”‚  â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚  ğŸ“‹ Conduta Imediata:                                â”‚   â”‚
â”‚  â”‚  1. O2 se SpO2 <90% (alvo 94-98%)                   â”‚   â”‚
â”‚  â”‚  2. Furosemida 40-80mg IV                            â”‚   â”‚
â”‚  â”‚  3. RestriÃ§Ã£o hÃ­drica (<1.5L/dia)                    â”‚   â”‚
â”‚  â”‚  4. Monitorar diurese, PA, eletrÃ³litos               â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚  ğŸ’Š MedicaÃ§Ãµes de UrgÃªncia:                          â”‚   â”‚
â”‚  â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”       â”‚   â”‚
â”‚  â”‚  â”‚ Furosemida                                â”‚       â”‚   â”‚
â”‚  â”‚  â”‚ â€¢ Dose: 40-80mg IV                        â”‚       â”‚   â”‚
â”‚  â”‚  â”‚ â€¢ FrequÃªncia: 12/12h                      â”‚       â”‚   â”‚
â”‚  â”‚  â”‚ â€¢ Monitorar: K+, Creatinina               â”‚       â”‚   â”‚
â”‚  â”‚  â”‚ [Ver bula] [InteraÃ§Ãµes]                   â”‚       â”‚   â”‚
â”‚  â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜       â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚  ğŸ“Š Calculadoras Ãšteis:                              â”‚   â”‚
â”‚  â”‚  [NYHA Class] [Dose Furosemida] [TFG]               â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚  ğŸ“„ Fluxograma:                                      â”‚   â”‚
â”‚  â”‚  [Ver Algoritmo de IC Aguda] [Download PDF]         â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚  âœ… Selo: Baseado em Diretriz SBC 2025              â”‚   â”‚
â”‚  â”‚  ğŸ“š ReferÃªncia: Diretriz SBC de IC 2025             â”‚   â”‚
â”‚  â”‚     Ãšltima revisÃ£o: 15/02/2026                       â”‚   â”‚
â”‚  â”‚     Revisado por: Dr. JoÃ£o Silva (CRM-SP 123456)    â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  ğŸ’¬ DiscussÃ£o (23 contribuiÃ§Ãµes)                            â”‚
â”‚  [Abrir thread] [Adicionar experiÃªncia de campo]           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Toggle entre NÃ­veis:**

**NÃ­vel 2 (Especialista):** Ativa quando usuÃ¡rio clica no toggle
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ“‹ CRITÃ‰RIOS DIAGNÃ“STICOS                                  â”‚
â”‚                                                              â”‚
â”‚  Framingham:                                                 â”‚
â”‚  â€¢ CritÃ©rios Maiores: [expandir lista]                      â”‚
â”‚  â€¢ CritÃ©rios Menores: [expandir lista]                      â”‚
â”‚                                                              â”‚
â”‚  Ecocardiograma:                                             â”‚
â”‚  â€¢ FE <40%: IC com FE reduzida (IC-FEr)                     â”‚
â”‚  â€¢ FE 40-49%: IC com FE intermediÃ¡ria                        â”‚
â”‚  â€¢ FE â‰¥50%: IC com FE preservada (IC-FEp)                   â”‚
â”‚                                                              â”‚
â”‚  ğŸ¯ ALGORITMO DE TRATAMENTO (IC-FEr)                        â”‚
â”‚                                                              â”‚
â”‚  Step 1: IECA ou BRA                                         â”‚
â”‚  â”œâ”€ Enalapril 5mg â†’ 10-20mg                                 â”‚
â”‚  â””â”€ Losartan 25mg â†’ 50-100mg                                â”‚
â”‚                                                              â”‚
â”‚  Step 2: Betabloqueador                                      â”‚
â”‚  â”œâ”€ Carvedilol 3.125mg â†’ 25mg 2x/dia                        â”‚
â”‚  â””â”€ Metoprolol succinato 12.5mg â†’ 200mg                     â”‚
â”‚                                                              â”‚
â”‚  Step 3: Espironolactona                                     â”‚
â”‚  â””â”€ 25mg â†’ 50mg (se K+ <5.0 e Creat <2.5)                   â”‚
â”‚                                                              â”‚
â”‚  Step 4: Sacubitril/Valsartan (se FE <35%)                  â”‚
â”‚  â””â”€ Substituir IECA/BRA apÃ³s 36h washout                    â”‚
â”‚                                                              â”‚
â”‚  âš ï¸ CONTRAINDICAÃ‡Ã•ES                                         â”‚
â”‚  â€¢ IECA: GestaÃ§Ã£o, Angioedema, Estenose bilateral renal    â”‚
â”‚  â€¢ Betabloqueador: BAV 2Âº/3Âº grau, Asma grave              â”‚
â”‚  â€¢ Espironolactona: K+ >5.0, Creat >2.5                     â”‚
â”‚                                                              â”‚
â”‚  ğŸ“Š MONITORAMENTO                                            â”‚
â”‚  â€¢ Baseline: Creatinina, K+, BNP, ECG, ECO                  â”‚
â”‚  â€¢ Follow-up: Creat e K+ em 1-2 sem, ECO em 6-12 meses     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**NÃ­vel 3 (PhD/Frontier):**
```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ§¬ MECANISMO FISIOPATOLÃ“GICO                               â”‚
â”‚                                                              â”‚
â”‚  [Diagrama Interativo 3D]                                    â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”     â”‚
â”‚  â”‚  Sobrecarga HemodinÃ¢mica                           â”‚     â”‚
â”‚  â”‚         â†“                                           â”‚     â”‚
â”‚  â”‚  Remodelamento Ventricular                         â”‚     â”‚
â”‚  â”‚         â†“                                           â”‚     â”‚
â”‚  â”‚  AtivaÃ§Ã£o Neuro-hormonal (SNS â†‘, SRAA â†‘)          â”‚     â”‚
â”‚  â”‚         â†“                                           â”‚     â”‚
â”‚  â”‚  RetenÃ§Ã£o de Na/H2O + VasoconstriÃ§Ã£o               â”‚     â”‚
â”‚  â”‚         â†“                                           â”‚     â”‚
â”‚  â”‚  DescompensaÃ§Ã£o ClÃ­nica                            â”‚     â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜     â”‚
â”‚  [Explorar mecanismo molecular]                              â”‚
â”‚                                                              â”‚
â”‚  ğŸ“š ÃšLTIMOS 5 RCTs RELEVANTES                               â”‚
â”‚                                                              â”‚
â”‚  1. EMPEROR-Preserved (2025) - Empagliflozin em IC-FEp     â”‚
â”‚     â”œâ”€ N: 5988                                              â”‚
â”‚     â”œâ”€ Endpoint: CV death ou HF hosp â†’ HR 0.79 (0.69-0.90) â”‚
â”‚     â”œâ”€ ConclusÃ£o: ReduÃ§Ã£o de 21% em eventos                â”‚
â”‚     â””â”€ [Ler abstract] [Ver grÃ¡fico Kaplan-Meier] [Citar]   â”‚
â”‚                                                              â”‚
â”‚  2. PARADIGM-HF (2024 - Follow-up 5 anos)                  â”‚
â”‚     â”œâ”€ Sacubitril/Valsartan vs Enalapril                    â”‚
â”‚     â”œâ”€ Benefit mantido em longo prazo                       â”‚
â”‚     â””â”€ [Ler] [Citar]                                        â”‚
â”‚                                                              â”‚
â”‚  [Ver todos os estudos]                                      â”‚
â”‚                                                              â”‚
â”‚  ğŸ¯ ALVOS MOLECULARES                                        â”‚
â”‚                                                              â”‚
â”‚  â€¢ Neprilisina (inibida por Sacubitril)                     â”‚
â”‚    â””â”€ â†‘ PeptÃ­deos natriurÃ©ticos â†’ vasodilataÃ§Ã£o            â”‚
â”‚                                                              â”‚
â”‚  â€¢ SGLT2 (inibida por Empagliflozin)                        â”‚
â”‚    â””â”€ Natriurese, â†“ remodelamento                           â”‚
â”‚                                                              â”‚
â”‚  âš ï¸ CONTROVÃ‰RSIAS E DEBATES                                  â”‚
â”‚                                                              â”‚
â”‚  "Timing de Sacubitril/Valsartan: Iniciar precocemente?"   â”‚
â”‚  â€¢ Debate: [Ler thread] [Adicionar opiniÃ£o]                â”‚
â”‚  â€¢ ReferÃªncias: PMID 35678902, PMID 35678903               â”‚
â”‚                                                              â”‚
â”‚  ğŸ“– EXPORTAR CITAÃ‡Ã•ES                                        â”‚
â”‚  [BibTeX] [RIS (EndNote)] [ABNT] [APA] [Vancouver]         â”‚
â”‚                                                              â”‚
â”‚  ğŸ”” Criar alerta para novos estudos de "InsuficiÃªncia CardÃ­aca" â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Tela 3: Lab Colaborativo

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â† Voltar    DiscussÃµes: InsuficiÃªncia CardÃ­aca            â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  [ğŸ” Buscar] [â• Nova DiscussÃ£o] [ğŸ† Top Contribuidores]    â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ ğŸ”¥ Hot Topic                                         â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚ ğŸ’¬ Timing de Sacubitril/Valsartan                    â”‚   â”‚
â”‚  â”‚    Por: Dra. Ana Silva (CRM-RJ 987654) â€¢ HÃ¡ 2 dias  â”‚   â”‚
â”‚  â”‚    â–² 23  ğŸ’¬ 8 respostas                              â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    "Tenho observado que muitos pacientes chegam     â”‚   â”‚
â”‚  â”‚     ao ambulatÃ³rio jÃ¡ em IECA otimizado. VocÃªs      â”‚   â”‚
â”‚  â”‚     iniciam Sacubitril imediatamente ou aguardam?" â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    [Expandir thread] [Responder]                     â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    Ãšltima resposta: Dr. Pedro Costa (InCor USP)     â”‚   â”‚
â”‚  â”‚    "Na nossa prÃ¡tica, aguardamos 4 semanas..."      â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ ğŸ“„ ExperiÃªncia de Campo                              â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚ ğŸ’¡ Caso de IC com FE recuperada apÃ³s Carvedilol     â”‚   â”‚
â”‚  â”‚    Por: Dr. Carlos Mendes (CRM-SP 123789) â€¢ HÃ¡ 5d   â”‚   â”‚
â”‚  â”‚    â–² 15  ğŸ’¬ 3 respostas                              â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    "Paciente com IC-FEr (FE 28%) apÃ³s IAM, iniciado â”‚   â”‚
â”‚  â”‚     em Carvedilol. ECO apÃ³s 6 meses: FE 55%..."     â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    [Ler mais] [Responder]                            â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ ğŸ“š SubmissÃ£o de ConteÃºdo                             â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚ ğŸ“ Novo estudo: "Dapagliflozin em IC-FEp"           â”‚   â”‚
â”‚  â”‚    Por: Dra. Fernanda Lima â€¢ HÃ¡ 1 semana            â”‚   â”‚
â”‚  â”‚    â–² 32  Status: âœ… Processado pela IA              â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    "Anexei o PDF do estudo DELIVER. A IA jÃ¡         â”‚   â”‚
â”‚  â”‚     sugeriu atualizaÃ§Ã£o na conduta de IC-FEp."      â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    [Ver sugestÃ£o da IA] [Votar] [Comentar]          â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  ğŸ“Š EstatÃ­sticas:                                            â”‚
â”‚  â€¢ 234 threads ativos                                        â”‚
â”‚  â€¢ 1.2k contribuiÃ§Ãµes (Ãºltimos 30 dias)                     â”‚
â”‚  â€¢ 89% de mÃ©dicos verificados                                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Funcionalidades:**
- **Thread System:** DiscussÃµes aninhadas (Reddit-like)
- **Upvote/Downvote:** ReputaÃ§Ã£o baseada em contribuiÃ§Ãµes
- **VerificaÃ§Ã£o:** Apenas mÃ©dicos com CRM podem postar
- **SubmissÃ£o de PDFs:** IA (Vertex AI Document AI) processa e sugere atualizaÃ§Ãµes
- **ModeraÃ§Ã£o:** Flagging system + moderadores

---

### Tela 4: Gestor de ReferÃªncias (My PhD)

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  â† Voltar    My PhD Library                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                              â”‚
â”‚  [ğŸ” Buscar] [â• Nova Pasta] [ğŸ“¤ Exportar Tudo] [âš™ï¸]        â”‚
â”‚                                                              â”‚
â”‚  ğŸ“ Minhas Pastas:                                           â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”        â”‚
â”‚  â”‚ ğŸ“• IC        â”‚ â”‚ ğŸ“˜ IAM       â”‚ â”‚ ğŸ“— Arritmias â”‚        â”‚
â”‚  â”‚ 45 artigos   â”‚ â”‚ 23 artigos   â”‚ â”‚ 12 artigos   â”‚        â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜        â”‚
â”‚                                                              â”‚
â”‚  ğŸ”¥ Recentemente Salvos:                                     â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ ğŸ“„ EMPEROR-Preserved: Empagliflozin in HF-PEF       â”‚   â”‚
â”‚  â”‚    Anker SD, Butler J et al.                        â”‚   â”‚
â”‚  â”‚    N Engl J Med. 2025;392:123-134                   â”‚   â”‚
â”‚  â”‚    PMID: 35678901                                    â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    Pasta: ğŸ“• IC                                      â”‚   â”‚
â”‚  â”‚    Salvo em: 15/02/2026                              â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    ğŸ“ Minhas Notas:                                  â”‚   â”‚
â”‚  â”‚    "Importante para minha revisÃ£o - empagliflozin   â”‚   â”‚
â”‚  â”‚     reduz eventos em 21%"                            â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    ğŸ–ï¸ Destaques: "HR 0.79", "FEp"                   â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    [Ler abstract] [PDF completo] [Citar] [Editar]   â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚ ğŸ“„ PARADIGM-HF: Sacubitril/Valsartan vs Enalapril   â”‚   â”‚
â”‚  â”‚    McMurray JJ et al.                                â”‚   â”‚
â”‚  â”‚    N Engl J Med. 2024;371:993-1004                   â”‚   â”‚
â”‚  â”‚    PMID: 25176015                                    â”‚   â”‚
â”‚  â”‚                                                       â”‚   â”‚
â”‚  â”‚    Pasta: ğŸ“• IC                                      â”‚   â”‚
â”‚  â”‚    [Citar] [Ver notas]                               â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                                                              â”‚
â”‚  ğŸ“¤ Exportar:                                                â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”‚
â”‚  â”‚ Selecione pasta: [ğŸ“• IC â–¼]                           â”‚  â”‚
â”‚  â”‚ Formato: [BibTeX â–¼] [RIS] [ABNT] [APA] [Vancouver]  â”‚  â”‚
â”‚  â”‚                                                        â”‚  â”‚
â”‚  â”‚ [ğŸ“¥ Exportar 45 artigos]                             â”‚  â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â”‚
â”‚                                                              â”‚
â”‚  ğŸ”” Alertas Configurados:                                    â”‚
â”‚  â€¢ "InsuficiÃªncia CardÃ­aca" - Semanal                       â”‚
â”‚  â€¢ "Sacubitril/Valsartan" - Mensal                          â”‚
â”‚  [Gerenciar alertas]                                         â”‚
â”‚                                                              â”‚
â”‚  ğŸ“Š EstatÃ­sticas:                                            â”‚
â”‚  â€¢ 80 artigos salvos                                         â”‚
â”‚  â€¢ 15 exportaÃ§Ãµes realizadas                                 â”‚
â”‚  â€¢ Ãšltima exportaÃ§Ã£o: 20/02/2026                             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

**Funcionalidades:**
- **OrganizaÃ§Ã£o por Pastas:** Arrastar e soltar
- **Notas e Destaques:** Annotations direto nos artigos
- **ExportaÃ§Ã£o Multi-formato:** BibTeX, RIS, ABNT, APA, Vancouver
- **Alertas AutomÃ¡ticos:** Novos estudos via PubMed RSS
- **SincronizaÃ§Ã£o:** Cloud sync (Firestore)

---

## ğŸ” Sistema de Busca SemÃ¢ntica

### Arquitetura de Busca

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                 USER QUERY                                   â”‚
â”‚   "Paciente 70 anos, IC com FE reduzida, qual dose de      â”‚
â”‚    Sacubitril/Valsartan?"                                    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚
                   â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚          NLP PROCESSING (Vertex AI)                          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  1. Entity Extraction:                                       â”‚
â”‚     - Age: 70 anos                                           â”‚
â”‚     - Condition: InsuficiÃªncia CardÃ­aca                      â”‚
â”‚     - Phenotype: FE reduzida (IC-FEr)                        â”‚
â”‚     - Intent: Dose de medicamento                            â”‚
â”‚     - Drug: Sacubitril/Valsartan                             â”‚
â”‚                                                               â”‚
â”‚  2. Query Embedding (text-embedding-004):                    â”‚
â”‚     vector[768] = [0.123, -0.456, ...]                       â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚
                   â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚          MULTI-SOURCE SEARCH                                 â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                                                               â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚   Firestore   â”‚  â”‚   BigQuery    â”‚  â”‚  Algolia      â”‚   â”‚
â”‚  â”‚   (Conducts)  â”‚  â”‚  (Analytics)  â”‚  â”‚  (Full-text)  â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚          â”‚                  â”‚                  â”‚            â”‚
â”‚          â”‚                  â”‚                  â”‚            â”‚
â”‚  Vector similarity    Context ranking    Keyword match      â”‚
â”‚  (cosine distance)    (PageRank-like)    (BM25)             â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
           â”‚                  â”‚                  â”‚
           â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚          RESULT FUSION & RANKING                             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Weighted Score:                                             â”‚
â”‚  - Vector similarity: 50%                                    â”‚
â”‚  - Keyword relevance: 30%                                    â”‚
â”‚  - Context (user specialty, recency): 20%                    â”‚
â”‚                                                               â”‚
â”‚  Results:                                                     â”‚
â”‚  1. Conduct: IC-FEr - Tratamento (Score: 0.95) âœ…           â”‚
â”‚  2. Drug: Sacubitril/Valsartan (Score: 0.92) âœ…             â”‚
â”‚  3. Calculator: Dose Sacubitril/Valsartan (Score: 0.88) âœ…  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚
                   â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚          ANSWER SYNTHESIS (Gemini Pro)                       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  Contexto: Paciente 70 anos com IC-FEr                      â”‚
â”‚  Resposta Sintetizada:                                       â”‚
â”‚                                                               â”‚
â”‚  "Para paciente com InsuficiÃªncia CardÃ­aca com FE reduzida, â”‚
â”‚   a dose de Sacubitril/Valsartan Ã©:                          â”‚
â”‚                                                               â”‚
â”‚   â€¢ Dose inicial: 49/51mg 2x/dia                             â”‚
â”‚   â€¢ Dobrar dose apÃ³s 2-4 semanas se tolerado                 â”‚
â”‚   â€¢ Dose alvo: 97/103mg 2x/dia                               â”‚
â”‚                                                               â”‚
â”‚   âš ï¸ Importante:                                              â”‚
â”‚   - Aguardar washout de 36h se estava em IECA               â”‚
â”‚   - Monitorar PA, K+, creatinina                             â”‚
â”‚   - Contraindicado se K+ >5.5 ou TFG <30                     â”‚
â”‚                                                               â”‚
â”‚   ğŸ“š ReferÃªncia: Diretriz SBC 2025, PARADIGM-HF"            â”‚
â”‚                                                               â”‚
â”‚  [Ver conduta completa] [Abrir calculadora]                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### ImplementaÃ§Ã£o TÃ©cnica

#### 1. **IndexaÃ§Ã£o de ConteÃºdo (Cloud Functions)**

```python
from google.cloud import aiplatform
from vertexai.language_models import TextEmbeddingModel

def index_conduct(conduct_data):
    """
    Gera embeddings para busca semÃ¢ntica
    """
    # Modelo de embedding
    model = TextEmbeddingModel.from_pretrained("text-embedding-004")
    
    # Texto a ser embeddado
    text = f"""
    {conduct_data['pathology']['name']}
    {conduct_data['layers']['layer_1_plantao']['summary']}
    {conduct_data['layers']['layer_2_especialista']['diagnostic_criteria']}
    """
    
    # Gerar embedding
    embeddings = model.get_embeddings([text])
    vector = embeddings[0].values  # 768-dimensional vector
    
    # Armazenar no Firestore
    conduct_ref = db.collection('conducts').document(conduct_data['id'])
    conduct_ref.update({
        'embedding': vector,
        'indexed_at': firestore.SERVER_TIMESTAMP
    })
```

#### 2. **Query Processing (Backend)**

```typescript
// services/search.ts
import { VertexAI } from '@google-cloud/aiplatform';
import { Firestore } from '@google-cloud/firestore';

interface SearchQuery {
  query: string;
  user_specialty?: string;
  filters?: {
    category?: string;
    evidence_level?: string;
  };
}

async function semanticSearch(query: SearchQuery) {
  // 1. Extract entities com Vertex AI NLP
  const entities = await extractEntities(query.query);
  
  // 2. Generate query embedding
  const queryVector = await generateEmbedding(query.query);
  
  // 3. Vector search in Firestore
  // (Note: Firestore nÃ£o tem vector search nativo, usar Algolia ou Vertex AI Vector Search)
  const vectorResults = await vertexVectorSearch(queryVector);
  
  // 4. Keyword search in Algolia
  const keywordResults = await algoliaSearch(query.query);
  
  // 5. Merge and rank
  const mergedResults = mergeResults(vectorResults, keywordResults, {
    weights: { vector: 0.5, keyword: 0.3, context: 0.2 },
    user_context: { specialty: query.user_specialty }
  });
  
  // 6. Synthesize answer com Gemini
  const answer = await synthesizeAnswer(query.query, mergedResults[0]);
  
  return {
    answer,
    results: mergedResults,
    entities
  };
}

async function extractEntities(text: string) {
  const model = vertex.preview.language.LanguageServiceClient();
  
  const document = {
    content: text,
    type: 'PLAIN_TEXT',
    language: 'pt'
  };
  
  const [result] = await model.analyzeEntities({ document });
  
  return {
    age: extractAge(result.entities),
    condition: extractCondition(result.entities),
    drug: extractDrug(result.entities),
    intent: classifyIntent(text)
  };
}
```

#### 3. **Algolia Index Configuration**

```javascript
// Algolia index settings
const index = client.initIndex('conducts');

index.setSettings({
  searchableAttributes: [
    'pathology.name',
    'pathology.synonyms',
    'pathology.cid10',
    'layers.layer_1_plantao.summary',
    'layers.layer_2_especialista.diagnostic_criteria',
    'layers.layer_3_phd.latest_rcts.title'
  ],
  attributesForFaceting: [
    'pathology.category',
    'trust_seal.level',
    'trust_seal.evidence_grade'
  ],
  customRanking: [
    'desc(analytics.views)',
    'desc(trust_seal.evidence_grade)',
    'desc(last_updated)'
  ],
  ranking: [
    'typo',
    'geo',
    'words',
    'filters',
    'proximity',
    'attribute',
    'exact',
    'custom'
  ]
});
```

---

## ğŸ”— IntegraÃ§Ã£o de APIs Externas

### 1. **ANVISA (Brasil)**

#### Web Scraping do DOU

```python
# cloud_functions/anvisa_scraper.py
import requests
from bs4 import BeautifulSoup
from google.cloud import bigquery

def scrape_dou_daily(request):
    """
    Scrape DiÃ¡rio Oficial da UniÃ£o para novos registros
    Cloud Function executada diariamente (Cloud Scheduler)
    """
    url = "https://www.in.gov.br/consulta"
    params = {
        'q': 'ANVISA registro medicamento',
        'publishDate': 'today'
    }
    
    response = requests.get(url, params=params)
    soup = BeautifulSoup(response.text, 'html.parser')
    
    # Parse registros
    registros = []
    for article in soup.find_all('article', class_='resultado'):
        titulo = article.find('h5').text
        if 'medicamento' in titulo.lower():
            registro = {
                'titulo': titulo,
                'data': article.find('span', class_='data').text,
                'url': article.find('a')['href'],
                'scrape_timestamp': datetime.now().isoformat()
            }
            registros.append(registro)
    
    # Insert into BigQuery
    client = bigquery.Client()
    table_id = "medfocus_lakehouse.raw_data.anvisa_raw"
    
    errors = client.insert_rows_json(table_id, registros)
    
    if not errors:
        print(f"Inserted {len(registros)} registros")
        # Trigger notification
        notify_new_anvisa_registrations(registros)
    else:
        print(f"Errors: {errors}")
    
    return {'status': 'success', 'count': len(registros)}

def notify_new_anvisa_registrations(registros):
    """
    Notifica usuÃ¡rios sobre novos registros relevantes
    """
    from google.cloud import pubsub_v1
    
    publisher = pubsub_v1.PublisherClient()
    topic_path = publisher.topic_path('medfocus', 'anvisa-updates')
    
    for registro in registros:
        message_json = json.dumps(registro)
        future = publisher.publish(topic_path, message_json.encode('utf-8'))
        print(f"Published message ID: {future.result()}")
```

#### BulÃ¡rio EletrÃ´nico API

```python
# services/anvisa_api.py
import requests

class AnvisaBularioAPI:
    BASE_URL = "https://consultas.anvisa.gov.br/api/consulta/bulario"
    
    def search_drug(self, nome_comercial: str = None, principio_ativo: str = None):
        """
        Busca medicamento no bulÃ¡rio ANVISA
        """
        params = {}
        if nome_comercial:
            params['nomeProduto'] = nome_comercial
        if principio_ativo:
            params['nomePrincipioAtivo'] = principio_ativo
        
        response = requests.get(f"{self.BASE_URL}/medicamentos", params=params)
        return response.json()
    
    def get_bula(self, numero_registro: str):
        """
        Baixa bula em PDF
        """
        url = f"{self.BASE_URL}/bula/{numero_registro}"
        response = requests.get(url)
        
        if response.status_code == 200:
            # Upload to GCS
            from google.cloud import storage
            client = storage.Client()
            bucket = client.bucket('medfocus-bulas')
            blob = bucket.blob(f"{numero_registro}.pdf")
            blob.upload_from_string(response.content, content_type='application/pdf')
            
            return blob.public_url
        else:
            return None
```

---

### 2. **OpenFDA (EUA)**

```python
# services/openfda_api.py
import requests
from datetime import datetime, timedelta

class OpenFDAAPI:
    BASE_URL = "https://api.fda.gov"
    
    def get_drug_labels(self, generic_name: str):
        """
        Busca labels (bulas) no FDA
        """
        url = f"{self.BASE_URL}/drug/label.json"
        params = {
            'search': f'openfda.generic_name:"{generic_name}"',
            'limit': 5
        }
        
        response = requests.get(url, params=params)
        data = response.json()
        
        # Extract black box warnings
        results = []
        for result in data.get('results', []):
            warnings = result.get('boxed_warning', [])
            results.append({
                'generic_name': generic_name,
                'brand_name': result.get('openfda', {}).get('brand_name', []),
                'black_box_warnings': warnings,
                'indications': result.get('indications_and_usage', []),
                'contraindications': result.get('contraindications', [])
            })
        
        return results
    
    def get_adverse_events(self, drug_name: str, days_back: int = 90):
        """
        Busca adverse events recentes
        """
        url = f"{self.BASE_URL}/drug/event.json"
        
        # Date range
        end_date = datetime.now()
        start_date = end_date - timedelta(days=days_back)
        date_range = f"[{start_date.strftime('%Y%m%d')}+TO+{end_date.strftime('%Y%m%d')}]"
        
        params = {
            'search': f'patient.drug.medicinalproduct:"{drug_name}"+AND+receivedate:{date_range}',
            'count': 'patient.reaction.reactionmeddrapt.exact'
        }
        
        response = requests.get(url, params=params)
        data = response.json()
        
        # Aggregate reactions
        reactions = []
        for item in data.get('results', []):
            reactions.append({
                'reaction': item.get('term'),
                'count': item.get('count')
            })
        
        # Sort by count
        reactions.sort(key=lambda x: x['count'], reverse=True)
        
        return reactions[:20]  # Top 20
```

---

### 3. **NCBI PubMed E-utilities**

```python
# services/pubmed_api.py
import requests
import xml.etree.ElementTree as ET

class PubMedAPI:
    BASE_URL = "https://eutils.ncbi.nlm.nih.gov/entrez/eutils"
    API_KEY = "YOUR_NCBI_API_KEY"  # Register at NCBI
    
    def search_rcts(self, condition: str, limit: int = 5):
        """
        Busca Ãºltimos 5 RCTs de uma condiÃ§Ã£o
        """
        # 1. ESearch - get PMIDs
        search_url = f"{self.BASE_URL}/esearch.fcgi"
        query = f'"{condition}"[Title/Abstract] AND "randomized controlled trial"[Publication Type] AND ("last 2 years"[PDat])'
        
        params = {
            'db': 'pubmed',
            'term': query,
            'retmax': limit,
            'retmode': 'json',
            'sort': 'pub date',
            'api_key': self.API_KEY
        }
        
        response = requests.get(search_url, params=params)
        data = response.json()
        pmids = data['esearchresult']['idlist']
        
        # 2. ESummary - get article details
        summary_url = f"{self.BASE_URL}/esummary.fcgi"
        params = {
            'db': 'pubmed',
            'id': ','.join(pmids),
            'retmode': 'json',
            'api_key': self.API_KEY
        }
        
        response = requests.get(summary_url, params=params)
        data = response.json()
        
        articles = []
        for pmid in pmids:
            article_data = data['result'][pmid]
            articles.append({
                'pmid': pmid,
                'title': article_data['title'],
                'authors': article_data['authors'],
                'journal': article_data['fulljournalname'],
                'pubdate': article_data['pubdate'],
                'doi': article_data.get('elocationid', ''),
                'abstract_url': f"https://pubmed.ncbi.nlm.nih.gov/{pmid}/"
            })
        
        # 3. EFetch - get abstracts
        for article in articles:
            abstract = self.fetch_abstract(article['pmid'])
            article['abstract'] = abstract
        
        return articles
    
    def fetch_abstract(self, pmid: str):
        """
        Busca abstract completo
        """
        url = f"{self.BASE_URL}/efetch.fcgi"
        params = {
            'db': 'pubmed',
            'id': pmid,
            'retmode': 'xml',
            'api_key': self.API_KEY
        }
        
        response = requests.get(url, params=params)
        root = ET.fromstring(response.content)
        
        abstract_texts = root.findall('.//AbstractText')
        abstract = ' '.join([text.text for text in abstract_texts if text.text])
        
        return abstract
    
    def export_citation(self, pmid: str, format: str = 'bibtex'):
        """
        Exporta citaÃ§Ã£o em formato especÃ­fico
        """
        # Fetch article data
        url = f"{self.BASE_URL}/efetch.fcgi"
        params = {
            'db': 'pubmed',
            'id': pmid,
            'retmode': 'xml',
            'api_key': self.API_KEY
        }
        
        response = requests.get(url, params=params)
        root = ET.fromstring(response.content)
        
        # Extract metadata
        article = root.find('.//Article')
        title = article.find('.//ArticleTitle').text
        journal = article.find('.//Journal/Title').text
        year = article.find('.//PubDate/Year').text
        authors = [f"{author.find('LastName').text}, {author.find('Initials').text}" 
                   for author in article.findall('.//Author')]
        
        if format == 'bibtex':
            return self._format_bibtex(pmid, title, authors, journal, year)
        elif format == 'ris':
            return self._format_ris(pmid, title, authors, journal, year)
        elif format == 'abnt':
            return self._format_abnt(pmid, title, authors, journal, year)
    
    def _format_bibtex(self, pmid, title, authors, journal, year):
        first_author_last_name = authors[0].split(',')[0]
        return f"""@article{{{first_author_last_name}{year},
  title={{{title}}},
  author={{{' and '.join(authors)}}},
  journal={{{journal}}},
  year={{{year}}},
  pmid={{{pmid}}}
}}"""
    
    def _format_ris(self, pmid, title, authors, journal, year):
        ris = f"TY  - JOUR\n"
        for author in authors:
            ris += f"AU  - {author}\n"
        ris += f"TI  - {title}\n"
        ris += f"T2  - {journal}\n"
        ris += f"PY  - {year}\n"
        ris += f"UR  - https://pubmed.ncbi.nlm.nih.gov/{pmid}/\n"
        ris += f"ER  - \n"
        return ris
    
    def _format_abnt(self, pmid, title, authors, journal, year):
        authors_str = '; '.join(authors)
        return f"{authors_str}. {title}. {journal}, {year}. DisponÃ­vel em: <https://pubmed.ncbi.nlm.nih.gov/{pmid}/>."
```

---

## ğŸ›¡ï¸ Sistema de Curadoria e Trust Layer

### Selo de VerificaÃ§Ã£o (Trust Seal)

#### NÃ­veis de Selo

```typescript
enum TrustLevel {
  GREEN = 'green',    // Baseado em Diretriz
  BLUE = 'blue',      // Consenso de Especialistas
  YELLOW = 'yellow'   // EvidÃªncia Emergente/PhD
}

interface TrustSeal {
  level: TrustLevel;
  description: string;
  validators: Validator[];
  evidence_grade: 'A' | 'B' | 'C' | 'D';
  last_review: Date;
  guideline_source?: {
    organization: string;  // "SBC", "AHA", "ESC"
    year: number;
    url: string;
  };
}

interface Validator {
  user_id: string;
  crm: string;
  specialty: string;
  institution: string;
  timestamp: Date;
  comments?: string;
}
```

#### CritÃ©rios de ValidaÃ§Ã£o

**Selo Verde (Green) - Baseado em Diretriz:**
- ConteÃºdo extraÃ­do diretamente de diretriz de sociedade mÃ©dica reconhecida
- Atualizada nos Ãºltimos 2 anos
- Validado por pelo menos 1 mÃ©dico especialista
- Evidence grade A ou B

**Selo Azul (Blue) - Consenso de Especialistas:**
- Validado por 3+ mÃ©dicos especialistas verificados
- De pelo menos 2 instituiÃ§Ãµes diferentes
- EvidÃªncia robusta (RCTs, meta-anÃ¡lises)
- Evidence grade B ou C

**Selo Amarelo (Yellow) - EvidÃªncia Emergente:**
- ConteÃºdo baseado em estudos recentes (< 6 meses)
- Ainda nÃ£o incorporado em diretrizes
- Validado por 2+ mÃ©dicos
- Evidence grade C ou D
- Tag "PhD/Frontier"

---

### Audit Trail (HistÃ³rico de EdiÃ§Ãµes)

```typescript
interface AuditEntry {
  editor: {
    user_id: string;
    name: string;
    crm: string;
  };
  timestamp: Date;
  changes: {
    field: string;
    old_value: any;
    new_value: any;
  }[];
  reason: string;
  approved_by: string[];  // user_ids de quem aprovou
  approval_status: 'pending' | 'approved' | 'rejected';
}

// Exemplo de uso
const audit_trail: AuditEntry[] = [
  {
    editor: {
      user_id: "user_dr_joao_123",
      name: "Dr. JoÃ£o Silva",
      crm: "CRM-SP 123456"
    },
    timestamp: new Date("2026-02-15T10:30:00Z"),
    changes: [
      {
        field: "layers.layer_1_plantao.key_drugs[0].dose",
        old_value: "40mg IV",
        new_value: "40-80mg IV"
      }
    ],
    reason: "AtualizaÃ§Ã£o conforme Diretriz SBC 2025 - dose pode ser ajustada",
    approved_by: ["user_dr_maria_456", "user_dr_carlos_789"],
    approval_status: "approved"
  }
];
```

#### Workflow de AprovaÃ§Ã£o

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  1. MÃ©dico Verificado propÃµe ediÃ§Ã£o                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚
                   â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  2. EdiÃ§Ã£o fica com status "pending"                         â”‚
â”‚     NotificaÃ§Ã£o enviada para curadores (3 mÃ©dicos)           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚
                   â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  3. Curadores revisam:                                       â”‚
â”‚     - âœ… Aprovam (2/3 votos â†’ aprovado)                      â”‚
â”‚     - âŒ Rejeitam (2/3 votos â†’ rejeitado)                    â”‚
â”‚     - ğŸ’¬ Pedem revisÃ£o (comentÃ¡rios)                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                   â”‚
                   â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  4. Se aprovado:                                             â”‚
â”‚     - EdiÃ§Ã£o aplicada ao conteÃºdo                            â”‚
â”‚     - Audit trail atualizado                                 â”‚
â”‚     - NotificaÃ§Ã£o ao editor original                         â”‚
â”‚     - Badge de "Contribuidor" para o editor                  â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

### Sistema de ReputaÃ§Ã£o

```typescript
interface UserReputation {
  user_id: string;
  total_points: number;
  level: number;  // 1-10
  badges: Badge[];
  contributions: {
    edits_proposed: number;
    edits_approved: number;
    edits_rejected: number;
    validations_performed: number;
    discussions_started: number;
    upvotes_received: number;
  };
}

interface Badge {
  id: string;
  name: string;
  description: string;
  icon_url: string;
  earned_at: Date;
}

// Exemplos de badges
const badges = {
  contributor: {
    name: "Contribuidor",
    description: "Primeira ediÃ§Ã£o aprovada",
    icon: "ğŸŒŸ"
  },
  expert_validator: {
    name: "Validador Expert",
    description: "100+ validaÃ§Ãµes realizadas",
    icon: "âœ…"
  },
  researcher: {
    name: "Pesquisador",
    description: "10+ artigos submetidos",
    icon: "ğŸ“š"
  },
  community_leader: {
    name: "LÃ­der ComunitÃ¡rio",
    description: "1000+ upvotes recebidos",
    icon: "ğŸ‘‘"
  }
};
```

---

## ğŸ’» Stack TecnolÃ³gica Completa

### Backend

```yaml
Cloud Platform: Google Cloud Platform (GCP)

Compute:
  - Cloud Run (microservices, serverless)
  - Cloud Functions (event-driven tasks)
  - Cloud Tasks (async job queue)

Databases:
  - Firestore (operational data, real-time)
  - Cloud SQL PostgreSQL (relational data)
  - BigQuery (data warehouse, analytics)
  - Memorystore Redis (caching, sessions)

Storage:
  - Cloud Storage (GCS) - files, PDFs, images
  - Vertex AI Vector Search (embeddings)

AI/ML:
  - Vertex AI (Gemini Pro, embeddings, NLP)
  - Document AI (PDF parsing)
  - Natural Language API (entity extraction)

Integration:
  - Cloud Pub/Sub (messaging)
  - Cloud Scheduler (cron jobs)
  - Workflows (orchestration)

Search:
  - Algolia (full-text search, faceted)
  - Vertex AI Vector Search (semantic)

Observability:
  - Cloud Logging
  - Cloud Monitoring
  - Cloud Trace
  - Error Reporting

Security:
  - Identity Platform (Firebase Auth)
  - Cloud Armor (DDoS protection)
  - Secret Manager (API keys)
  - Cloud KMS (encryption)

Languages & Frameworks:
  - Node.js 20.x + TypeScript 5.x
  - Python 3.12 + FastAPI
  - Express.js 4.x
```

### Frontend

```yaml
Web:
  - React 19.x
  - TypeScript 5.x
  - Vite 7.x (build tool)
  - TailwindCSS 4.x
  - Radix UI (components)
  - tRPC (type-safe API)
  - React Query (data fetching)
  - Zustand (state management)
  - React Hook Form (forms)
  - Recharts (charts)

Mobile:
  - Flutter 3.x
  - Dart 3.x
  - Riverpod (state management)
  - Hive (local database, offline)
  - Dio (HTTP client)
  - Flutter Hooks

PWA:
  - Service Worker (offline-first)
  - IndexedDB (client-side storage)
  - Web Push API (notifications)

Design:
  - Figma (design system)
  - Framer Motion (animations)
```

### DevOps & CI/CD

```yaml
Version Control:
  - GitHub (repositories)
  - Git Flow (branching strategy)

CI/CD:
  - GitHub Actions
  - Cloud Build

Infrastructure as Code:
  - Terraform
  - Cloud Deployment Manager

Containers:
  - Docker
  - Artifact Registry (container registry)

Monitoring:
  - Datadog (APM)
  - Sentry (error tracking)
  - Uptime Robot (uptime monitoring)
```

---

## ğŸ“… Roadmap de ImplementaÃ§Ã£o

### Phase 1: MVP Foundations (Q1 2026 - 3 meses)

**Objetivo:** Paridade com Whitebook + Infraestrutura GCP

#### MÃªs 1: Infraestrutura e Backend Base
- âœ… Setup GCP project
- âœ… Microservices architecture (Auth, Content, Clinical Decision)
- âœ… Firestore schema implementation
- âœ… Auth Service (JWT + CRM verification)
- âœ… Content Service MVP (100 condutas essenciais)

#### MÃªs 2: Features Core
- âœ… Drug Database MVP (500 medicamentos)
- âœ… Calculadoras mÃ©dicas (Top 50)
- âœ… ANVISA integration (BulÃ¡rio EletrÃ´nico)
- âœ… OpenFDA integration (Black Box Warnings)
- âœ… Web app (React) - Telas 1 e 2 (Cockpit + Camadas)

#### MÃªs 3: Busca e Mobile
- âœ… Sistema de busca semÃ¢ntica (Vertex AI + Algolia)
- âœ… Flutter app MVP (iOS + Android)
- âœ… Offline-first (Hive local storage)
- âœ… PWA implementation (Service Worker)
- âœ… Deploy e testes beta

**EntregÃ¡veis:**
- âœ… 100 condutas mÃ©dicas (layers 1 e 2)
- âœ… 500 medicamentos com interaÃ§Ãµes
- âœ… 50 calculadoras mÃ©dicas
- âœ… Apps web e mobile funcionais
- âœ… Busca semÃ¢ntica operacional

---

### Phase 2: Research & Collaboration (Q2 2026 - 3 meses)

**Objetivo:** Modo PhD + Lab Colaborativo

#### MÃªs 4: Research Service
- âœ… PubMed E-utilities integration
- âœ… Layer 3 (PhD) implementation
- âœ… Export de citaÃ§Ãµes (BibTeX/RIS/ABNT)
- âœ… Ãšltimos 5 RCTs automÃ¡ticos por condiÃ§Ã£o
- âœ… Tela 4 (My PhD Library)

#### MÃªs 5: Collaboration Tools
- âœ… Collaboration Service (threads, replies)
- âœ… Tela 3 (Lab Colaborativo)
- âœ… Sistema de upvote/downvote
- âœ… ModeraÃ§Ã£o e flagging
- âœ… NotificaÃ§Ãµes real-time (Firestore listeners)

#### MÃªs 6: Trust Layer
- âœ… Sistema de curadoria (3 mÃ©dicos)
- âœ… Audit trail completo
- âœ… Selo de verificaÃ§Ã£o (Green/Blue/Yellow)
- âœ… Sistema de reputaÃ§Ã£o e badges
- âœ… PDF submission + IA parsing (Document AI)

**EntregÃ¡veis:**
- âœ… Modo PhD funcional (layer 3)
- âœ… Lab colaborativo ativo
- âœ… Sistema de validaÃ§Ã£o robusto
- âœ… 300+ condutas mÃ©dicas completas (3 layers)

---

### Phase 3: Data Lakehouse & Intelligence (Q3 2026 - 3 meses)

**Objetivo:** BigQuery Data Lake + Analytics Preditivo

#### MÃªs 7: Data Pipeline
- âœ… BigQuery lakehouse setup
- âœ… Cloud Dataflow pipelines (ETL)
- âœ… ANVISA DOU scraping diÃ¡rio
- âœ… Sociedades mÃ©dicas RSS feeds
- âœ… Enrichment automÃ¡tico de drugs

#### MÃªs 8: Analytics Service
- âœ… Analytics Service (tracking, metrics)
- âœ… User behavior analysis
- âœ… Content performance dashboard
- âœ… A/B testing framework
- âœ… Search query analysis

#### MÃªs 9: ML & Recommendations
- âœ… Vertex AI model training (recommendations)
- âœ… PrediÃ§Ã£o de necessidades de estudo
- âœ… Weak areas identification
- âœ… Alertas inteligentes de novos estudos
- âœ… Dashboard de analytics para admins

**EntregÃ¡veis:**
- âœ… Data lakehouse operacional
- âœ… Analytics preditivo funcionando
- âœ… RecomendaÃ§Ãµes personalizadas
- âœ… 1000+ condutas mÃ©dicas

---

### Phase 4: Scale & Expansion (Q4 2026 - 3 meses)

**Objetivo:** ExpansÃ£o de conteÃºdo + Parcerias

#### MÃªs 10: ConteÃºdo Massivo
- âœ… ExpansÃ£o para 2000+ condutas
- âœ… Drug database completo (3000+ medicamentos)
- âœ… 100+ calculadoras
- âœ… Guidelines de 20+ sociedades mÃ©dicas
- âœ… Atlas de imagens mÃ©dicas (500+ imagens)

#### MÃªs 11: Advanced Features
- âœ… API pÃºblica v1
- âœ… Webhooks para integraÃ§Ãµes
- âœ… Modo escuro
- âœ… Multilingual (EN, ES)
- âœ… Voice search (Speech-to-Text)

#### MÃªs 12: Go-to-Market
- âœ… Beta launch (mÃ©dicos selecionados)
- âœ… Parcerias com universidades
- âœ… IntegraÃ§Ã£o com sistemas hospitalares
- âœ… Planos de assinatura (freemium)
- âœ… Marketing e PR

**EntregÃ¡veis:**
- âœ… Plataforma completa e escalÃ¡vel
- âœ… 2000+ condutas, 3000+ medicamentos
- âœ… API pÃºblica documentada
- âœ… 10.000+ usuÃ¡rios ativos (meta)

---

## ğŸ’° Estimativas e Recursos

### Budget Estimado

#### Infraestrutura (GCP)

**MVP (Fase 1-2, atÃ© 1.000 usuÃ¡rios ativos):**
```
Cloud Run (microservices):        $200/mÃªs
Firestore (reads/writes):          $150/mÃªs
Cloud SQL PostgreSQL (db-f1-micro): $50/mÃªs
Memorystore Redis (1GB):          $100/mÃªs
Cloud Storage (GCS):               $30/mÃªs
Vertex AI (Gemini Pro):           $300/mÃªs (estimativa)
Algolia (Search):                 $100/mÃªs
Cloud Functions:                   $50/mÃªs
Cloud Tasks:                       $20/mÃªs
Networking:                        $50/mÃªs
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Total MVP:                      ~$1.050/mÃªs
```

**Scale (Fase 3-4, atÃ© 10.000 usuÃ¡rios ativos):**
```
Cloud Run (auto-scale):          $800/mÃªs
Firestore:                       $600/mÃªs
Cloud SQL (db-n1-standard-2):    $250/mÃªs
Memorystore Redis (5GB):         $350/mÃªs
Cloud Storage:                   $150/mÃªs
Vertex AI:                     $1.000/mÃªs
Algolia:                         $300/mÃªs
BigQuery:                        $400/mÃªs
Cloud Functions:                 $150/mÃªs
Cloud Tasks:                      $50/mÃªs
Networking + CDN:                $200/mÃªs
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Total Scale:                   ~$4.250/mÃªs
```

**ProduÃ§Ã£o (100.000 usuÃ¡rios ativos):**
```
Estimativa:                  $15.000-25.000/mÃªs
```

---

#### Equipe Recomendada

**Fase 1-2 (MVP):**
```
1x Tech Lead (Backend)         $8k-12k/mÃªs
1x Senior Backend Engineer     $6k-10k/mÃªs
1x Senior Frontend Engineer    $6k-10k/mÃªs
1x Mobile Engineer (Flutter)   $6k-10k/mÃªs
1x DevOps Engineer             $6k-10k/mÃªs
1x Product Designer (UI/UX)    $5k-8k/mÃªs
1x Product Manager             $6k-10k/mÃªs
1x QA Engineer                 $4k-7k/mÃªs
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Total Equipe:              $47k-77k/mÃªs
                           $564k-924k/ano
```

**Fase 3-4 (Scale):**
```
+ 1x Backend Engineer          $6k-10k/mÃªs
+ 1x Data Engineer (BigQuery)  $7k-12k/mÃªs
+ 1x ML Engineer (Vertex AI)   $8k-14k/mÃªs
+ 1x Content Manager (mÃ©dico)  $5k-8k/mÃªs
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Total adicional:           $26k-44k/mÃªs

Total Equipe (Scale):      $73k-121k/mÃªs
                           $876k-1.452M/ano
```

---

#### Ferramentas e LicenÃ§as

```
GitHub Team:                      $4/user/mÃªs
Figma Professional:              $12/user/mÃªs
Datadog APM:                    $15/host/mÃªs
Sentry (Error Tracking):         $26/mÃªs (Team)
Algolia (Search):               $100-300/mÃªs
Domain + SSL:                    $50/ano
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Total:                        ~$500/mÃªs
```

---

#### Marketing e AquisiÃ§Ã£o

```
Google Ads:                  $2.000-5.000/mÃªs
Facebook/Instagram Ads:      $1.000-3.000/mÃªs
Content Marketing:           $1.000-2.000/mÃªs
PR e eventos:                $1.000-3.000/mÃªs
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
Total:                       $5.000-13.000/mÃªs
```

---

### Budget Total Resumido (Ano 1)

```
Infraestrutura (GCP):         $50.000-80.000
Equipe (8-12 pessoas):       $564.000-1.452.000
Ferramentas:                   $6.000
Marketing:                    $60.000-156.000
Legal/Contabilidade:          $20.000
ContingÃªncia (10%):           $70.000-170.000
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
TOTAL ANO 1:              $770.000-1.884.000
```

**Budget conservador (MVP focus):** ~$800k  
**Budget agressivo (Scale fast):** ~$1.5M-2M

---

### ROI Estimado

#### Modelo de Receita (Freemium)

**Planos:**
```
Free (Estudantes):
  - 100 condutas
  - 20 calculadoras
  - Sem PhD mode
  - Ads

Basic ($10/mÃªs):
  - Acesso completo a condutas (layer 1-2)
  - Todas calculadoras
  - Drug database
  - Sem ads

Pro ($30/mÃªs):
  - Tudo do Basic
  - PhD mode (layer 3)
  - My PhD Library
  - ExportaÃ§Ã£o de citaÃ§Ãµes
  - Alertas ilimitados

Institucional ($500-2.000/mÃªs):
  - LicenÃ§a para hospitais/universidades
  - API access
  - White-label (futuro)
  - Suporte dedicado

Professores:
  - FREE (acesso completo)
  - Ferramentas de curadoria
```

#### ProjeÃ§Ã£o de UsuÃ¡rios e Receita

**Ano 1:**
```
Q1: 1.000 usuÃ¡rios (beta)
    - Free: 900
    - Basic: 80 ($800/mÃªs)
    - Pro: 20 ($600/mÃªs)
    MRR: $1.400

Q2: 5.000 usuÃ¡rios
    - Free: 4.000
    - Basic: 800 ($8.000/mÃªs)
    - Pro: 200 ($6.000/mÃªs)
    MRR: $14.000

Q3: 15.000 usuÃ¡rios
    - Free: 12.000
    - Basic: 2.400 ($24.000/mÃªs)
    - Pro: 600 ($18.000/mÃªs)
    MRR: $42.000

Q4: 30.000 usuÃ¡rios
    - Free: 24.000
    - Basic: 4.800 ($48.000/mÃªs)
    - Pro: 1.200 ($36.000/mÃªs)
    MRR: $84.000
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
ARR (Q4): $1.008.000
```

**Break-even:** ~18 meses (com growth moderado)

---

## ğŸ¯ PrÃ³ximos Passos Imediatos

### Prioridade P0 (PrÃ³ximos 7 dias)

1. **Definir Modelo de Dados Final:**
   - âœ… Revisar estrutura Firestore proposta
   - âœ… Validar com equipe tÃ©cnica
   - âœ… Criar scripts de migraÃ§Ã£o (se necessÃ¡rio)

2. **Prototipar Telas:**
   - âœ… Figma mockups das 4 telas principais
   - âœ… Validar UX com mÃ©dicos (5-10 usuÃ¡rios)
   - âœ… Iterar baseado em feedback

3. **Setup GCP Project:**
   - âœ… Criar projeto GCP
   - âœ… Configurar billing
   - âœ… Setup Terraform (IaC)
   - âœ… Deploy de microservice bÃ¡sico (Auth Service)

4. **Kick-off TÃ©cnico:**
   - âœ… Definir sprints (2 semanas)
   - âœ… Criar backlog no Jira/Linear
   - âœ… Setup repositÃ³rios GitHub
   - âœ… Configurar CI/CD (GitHub Actions)

---

### Perguntas para DiscussÃ£o

1. **Budget:** Qual Ã© o budget disponÃ­vel? MVP ($800k) ou Scale ($1.5M-2M)?

2. **Timeline:** 12 meses para v1 Ã© viÃ¡vel? HÃ¡ flexibilidade?

3. **Equipe:** Contratar full-time ou outsourcing parcial?

4. **Modelo de Dados:** Firestore (proposto) vs PostgreSQL como primary database?
   - Firestore: Melhor para real-time, escalabilidade, mobile-first
   - PostgreSQL: Melhor para queries complexas, joins, transaÃ§Ãµes

5. **Modo PhD:** Ã‰ MVP ou pode ser Fase 2?

6. **Parcerias:** HÃ¡ interesse em parcerias com universidades/hospitais desde o inÃ­cio?

7. **RegulatÃ³rio:** Precisamos de certificaÃ§Ã£o ANVISA ou CFM?

---

## ğŸ“š ReferÃªncias e Recursos

### DocumentaÃ§Ã£o TÃ©cnica
- [Google Cloud Platform](https://cloud.google.com/docs)
- [Vertex AI](https://cloud.google.com/vertex-ai/docs)
- [Firestore](https://firebase.google.com/docs/firestore)
- [Flutter](https://flutter.dev/docs)
- [React](https://react.dev/)

### APIs
- [ANVISA BulÃ¡rio](https://consultas.anvisa.gov.br/)
- [OpenFDA API](https://open.fda.gov/apis/)
- [NCBI E-utilities](https://www.ncbi.nlm.nih.gov/books/NBK25501/)

### InspiraÃ§Ã£o
- [Whitebook](https://whitebook.com.br/)
- [UpToDate](https://www.uptodate.com/)
- [AMBOSS](https://www.amboss.com/)
- [EHR Go](https://ehrgo.com/)

---

**Documento Preparado Por:** Equipe MedFocus  
**Data:** Fevereiro 2026  
**VersÃ£o:** 1.0 PhD  
**PrÃ³xima RevisÃ£o:** Definir apÃ³s kick-off  

---

## ğŸ“ PrÃ³xima AÃ§Ã£o

**VocÃª decide:**

**OpÃ§Ã£o A:** Desenhar modelo de dados Firestore detalhado para todas as collections  
**OpÃ§Ã£o B:** Criar protÃ³tipo Figma das telas de colaboraÃ§Ã£o  
**OpÃ§Ã£o C:** Definir arquitetura GCP completa com diagrama de serviÃ§os  
**OpÃ§Ã£o D:** Planejar pipeline de ingestÃ£o de dados (ANVISA, FDA, PubMed)  

**Qual caminho seguimos?**
